The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection

Park, Myeong Soo; Kwon, Bin; Ku, Seockmo; Ji, Geun Eog

doi:10.3390/nu9080887

Open AccessShort Note

The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection

by

Myeong Soo Park

¹,

Bin Kwon

²,

Seockmo Ku

³

and

Geun Eog Ji

^2,4,*

¹

Department of Hotel Culinary Arts, Yeonsung University, Anyang 430-749, Korea

²

Research Center, BIFIDO Co. Ltd., Hongcheon 250-804, Korea

³

Fermentation Science Program, School of Agribusiness and Agriscience, College of Basic and Applied Sciences, Middle Tennessee State University, Murfreesboro, TN 37132, USA

⁴

Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University, Seoul 151-742, Korea

^*

Author to whom correspondence should be addressed.

Nutrients 2017, 9(8), 887; https://doi.org/10.3390/nu9080887

Submission received: 5 July 2017 / Revised: 26 July 2017 / Accepted: 4 August 2017 / Published: 16 August 2017

(This article belongs to the Special Issue Prebiotics and Probiotics)

Download Versions Notes

Abstract

A total of 57 infants hospitalized with rotavirus disease were included in this study. The children were randomly divided into the study’s two treatment groups: three days of the oral administration of (i) a probiotics formula containing both Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 (N = 28); or (ii) a placebo (probiotic-free skim milk, N = 29) and the standard therapy for diarrhea. There were no differences in age, sex, or blood characteristics between the two groups. When the 57 cases completed the protocol, the duration of the patients’ diarrhea was significantly shorter in the probiotics group (4.38 ± 1.29, N = 28) than the placebo group (5.61 ± 1.23, N = 29), with a p-value of 0.001. Symptoms such as duration of fever (p = 0.119), frequency of diarrhea (p = 0.119), and frequency of vomiting (p = 0.331) tended to be ameliorated by the probiotic treatment; however, differences were not statistically significant between the two groups. There were no serious, adverse events and no differences in the frequency of adverse events in both groups.

Keywords: probiotics; rotavirus; Bifidobacterium; Lactobacillus

Share and Cite

MDPI and ACS Style

Park, M.S.; Kwon, B.; Ku, S.; Ji, G.E. The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection. Nutrients 2017, 9, 887. https://doi.org/10.3390/nu9080887

AMA Style

Park MS, Kwon B, Ku S, Ji GE. The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection. Nutrients. 2017; 9(8):887. https://doi.org/10.3390/nu9080887

Chicago/Turabian Style

Park, Myeong Soo, Bin Kwon, Seockmo Ku, and Geun Eog Ji. 2017. "The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection" Nutrients 9, no. 8: 887. https://doi.org/10.3390/nu9080887

APA Style

Park, M. S., Kwon, B., Ku, S., & Ji, G. E. (2017). The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection. Nutrients, 9(8), 887. https://doi.org/10.3390/nu9080887

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

The Efficacy of Bifidobacterium longum BORI and Lactobacillus acidophilus AD031 Probiotic Treatment in Infants with Rotavirus Infection

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI